EMA: Guideline on the acceptability of names for veterinary medicinal products processed through the centralised procedure

A Community marketing authorisation is valid throughout the European Union and the invented name of the medicinal product is an integral part of the authorisation.The centralised procedure therefore requires one single invented name for the medicinal product to be authorised. However, in exceptional cases, where the proposed trade mark has been cancelled, opposed or objected to under trade mark law in a Member State, the Commission may accept the existence of more than one name for a single product, in order not to disadvantage access to the concerned medicinal product in that Member State.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny